Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Preferred Dividend Payments (2021 - 2025)

PAVmed has reported Preferred Dividend Payments over the past 5 years, most recently at $91000.0 for Q4 2025.

  • Quarterly results put Preferred Dividend Payments at $91000.0 for Q4 2025, up 137.3% from a year ago — trailing twelve months through Dec 2025 was $355000.0 (up 7200.0% YoY), and the annual figure for FY2025 was $356000.0, changed.
  • Preferred Dividend Payments for Q4 2025 was $91000.0 at PAVmed, up from $90000.0 in the prior quarter.
  • Over the last five years, Preferred Dividend Payments for PAVM hit a ceiling of $91000.0 in Q4 2025 and a floor of -$244000.0 in Q4 2024.
  • Median Preferred Dividend Payments over the past 5 years was $75000.0 (2021), compared with a mean of $60000.0.
  • Biggest five-year swings in Preferred Dividend Payments: plummeted 412.82% in 2024 and later soared 137.3% in 2025.
  • PAVmed's Preferred Dividend Payments stood at $67000.0 in 2021, then increased by 7.46% to $72000.0 in 2022, then increased by 8.33% to $78000.0 in 2023, then plummeted by 412.82% to -$244000.0 in 2024, then soared by 137.3% to $91000.0 in 2025.
  • The last three reported values for Preferred Dividend Payments were $91000.0 (Q4 2025), $90000.0 (Q3 2025), and $88000.0 (Q2 2025) per Business Quant data.